Literature DB >> 1393267

Purinoceptors mediating relaxation and spasm in the rat gastric fundus.

M S Matharu1, M Hollingsworth.   

Abstract

1. The relaxant and spasmogenic effects of purines and analogues were studied in longitudinal strips of rat gastric fundus to characterize the purinoceptors involved. Classification was studied by use of agonist potency orders and of antagonists in circumstances where the influence of confounding factors was reduced. In general tone was raised by carbachol (0.1 microM). 2. Adenosine produced relaxation and was potentiated by nitrobenzylthioinosine (NBTI, 0.3 and 30 microM), an adenosine-uptake inhibitor. 8-Sulphophenyl-theophylline (8-SPT, 30 microM), a selective P1-purinoceptor antagonist, antagonized adenosine and 5'-N-ethylcarboxamidoadenosine (NECA), a selective agonist at P1-purinoceptors. 3. At resting tone, adenosine 5'-triphosphate (ATP) induced a small, phasic relaxation followed by a maintained spasm. When tone was raised by carbachol, ATP induced a larger relaxation followed by a smaller spasm. NBTI did not potentiate ATP, nor did 8-SPT antagonize ATP, suggesting that ATP does not act directly or indirectly at P1-purinoceptors. 4. With raised tone, and in the presence of indomethacin (10 microM) and 8-SPT (30 microM), 2-methylthio ATP (2-MeSATP) and ATP produced relaxations followed by spasms while alpha,beta-methylene ATP (alpha,beta-MeATP) induced only relaxation; all responses were concentration-dependent. The compounds had similar slopes and maxima for relaxation and spasm. The rank orders of potency were 2-MeSATP much greater than alpha,beta-MeATP greater than ATP for relaxation and 2-MeSATP much greater than ATP for spasm.5. With raised tone, and in the presence of indomethacin and alpha 8-SPT, desensitization to alpha,beta-MeATP (100microM) completely and only slightly suppressed responses to ATP and 2-MeSATP, respectively, as relaxants but had no effect on relaxant responses to adenosine. The magnitude of the spasms to ATP and 2-MeSATP was considerably increased by desensitization with alpha,beta-MeATP but the spasm to KCl was not affected.6. With raised tone, and in the presence of indomethacin and 8-SPT, reactive blue 2 (10 AM) nonselectively antagonized ATP, 2-MeATP, a,P-MeATP, adenosine and isoprenaline as relaxants. Reactive blue 2 prevented the spasms to ATP and 2-MeSATP but not spasm to KC1.7. With raised tone, and in the presence of indomethacin, suramin (100 microM) antagonized ATP, but not adenosine, as relaxants and antagonized ATP, but not KC1, as spasmogens.8. It is proposed that adenosine is susceptible to nucleoside-specific uptake and acts predominantly via a P,-purinoceptor and also by a non-PI-purinoceptor mechanism. ATP- and alpha,beta-MeATP-induced relaxations probably occur via a P2x-purinoceptor. The anomalous nature of the 2-MeSATP-induced relaxation suggests it acts both via a P2x-purinoceptor and an additional mechanism. A P2y-purinoceptor is most likely to be involved in the spasms to ATP and 2-MeSATP. Therefore, the functional nature of the responses mediated by P2X- and P2y-purinoceptors, relaxation and spasm respectively, are opposite to those seen in most smooth muscles.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1393267      PMCID: PMC1907523          DOI: 10.1111/j.1476-5381.1992.tb14346.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

1.  Interaction of adenine nucleotides, UTP and suramin in mouse vas deferens: suramin-sensitive and suramin-insensitive components in the contractile effect of ATP.

Authors:  I von Kügelgen; R Bültmann; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

2.  Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells.

Authors:  D van Calker; M Müller; B Hamprecht
Journal:  J Neurochem       Date:  1979-11       Impact factor: 5.372

3.  Characterization of P2x-receptors in rabbit isolated ear artery.

Authors:  S E O'Connor; B E Wood; P Leff
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

4.  Suramin is a slowly-equilibrating but competitive antagonist at P2x-receptors in the rabbit isolated ear artery.

Authors:  P Leff; B E Wood; S E O'Connor
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

Review 5.  P1- and P2-purinoceptor subtypes--an update.

Authors:  C Kennedy
Journal:  Arch Int Pharmacodyn Ther       Date:  1990 Jan-Feb

Review 6.  Further subclassification of ATP receptors based on agonist studies.

Authors:  S E O'Connor; I A Dainty; P Leff
Journal:  Trends Pharmacol Sci       Date:  1991-04       Impact factor: 14.819

7.  A study of the purinoceptors mediating contraction in the rat colon.

Authors:  S J Bailey; S M Hourani
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

8.  Phosphatidylinositol 4,5-bisphosphate hydrolysis in turkey erythrocytes is regulated by P2y purinoceptors.

Authors:  C P Berrie; P T Hawkins; L R Stephens; T K Harden; C P Downes
Journal:  Mol Pharmacol       Date:  1989-04       Impact factor: 4.436

9.  Suramin antagonizes responses to P2-purinoceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder and taenia coli.

Authors:  C H Hoyle; G E Knight; G Burnstock
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

10.  Effect of adenosine triphosphate and related purines in the rat gastric fundus.

Authors:  R A Lefebvre; G Burnstock
Journal:  Arch Int Pharmacodyn Ther       Date:  1990 Jan-Feb
View more
  11 in total

1.  ATP and endogenous agonists inhibit evoked [3H]-noradrenaline release in rat iris via A1 and P2y-like purinoceptors.

Authors:  H Fuder; U Muth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-10       Impact factor: 3.000

2.  ATP and nitric oxide: inhibitory NANC neurotransmitters in the longitudinal muscle-myenteric plexus preparation of the rat ileum.

Authors:  G J Smits; R A Lefebvre
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

3.  Evidence for an apamin-sensitive, but not purinergic, component in the nonadrenergic noncholinergic relaxation of the rat gastric fundus.

Authors:  Diego Currò; Teresina De Marco; Paolo Preziosi
Journal:  Br J Pharmacol       Date:  2004-10-25       Impact factor: 8.739

4.  Evidence that adenosine 5'-triphosphate is the third inhibitory non-adrenergic non-cholinergic neurotransmitter in the rat gastric fundus.

Authors:  K M Jenkinson; J J Reid
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

5.  The P(2)-purinoceptor antagonist suramin is a competitive antagonist at vasoactive intestinal peptide receptors in the rat gastric fundus.

Authors:  K M Jenkinson; J J Reid
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

6.  Rise in cytosolic Ca2+ concentration induced by P2-purinoceptor activation in isolated myocytes from the rat gastrointestinal tract.

Authors:  H M Blottière; G Loirand; P Pacaud
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

7.  Evidence for the presence of both pre- and postjunctional P2-purinoceptor subtypes in human isolated urinary bladder.

Authors:  S Palea; C Pietra; D G Trist; W Artibani; A Calpista; M Corsi
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

8.  Effects of hyperhomocysteinemia on non-adrenergic non-cholinergic relaxation in isolated rat duodenum.

Authors:  Edibe Karasu; Gülay Sadan; Arda Tasatargil
Journal:  Dig Dis Sci       Date:  2008-06-06       Impact factor: 3.199

9.  Contractions mediated by alpha 1-adrenoceptors and P2-purinoceptors in a cat colon circular muscle.

Authors:  K Venkova; A Milne; J Krier
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

10.  P2-purinoceptors mediating spasm of the isolated uterus of the non-pregnant guinea-pig.

Authors:  A S Piper; M Hollingsworth
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.